Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study

Alzheimer s & Dementia(2020)10.1002/alz.12229Source: DataRank Database

Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study is a research paper published in Alzheimer s & Dementia (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access40 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)OA: hybridTopics (50)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

M. Florencia Iulita ORCID,Adriana Ducatenzeiler,Laura Videla ORCID,Bessy Benejam ORCID,María Carmona‐Iragui ORCID

Live enrichment

PubMed:33226181 PMC:PMC8043977

National Institutes of Health

Grant: RO1‐AG056850

Instituto de Salud Carlos III

Grant: PI14/01126

Instituto de Salud Carlos III

Grant: PI17/01019

Instituto de Salud Carlos III

Grant: PI13/01532

Instituto de Salud Carlos III

Grant: PI16/01825

Instituto de Salud Carlos III

Grant: PI18/00335

Instituto de Salud Carlos III

Grant: PI14/1561

Instituto de Salud Carlos III

Grant: PI17/01896

National Institutes of Health

Grant: R21AG056974

National Institutes of Health

Grant: R01AG061566

Fundació la Marató de TV3

Grant: 20141210

Fundació la Marató de TV3

Grant: 044412

Generalitat de Catalunya

Grant: SLT006/17/00119

NIA NIH HHS

Grant: RF1 AG061566

NIA NIH HHS

Grant: RF1 AG056850

European Regional Development Fund

hybridLicense: cc-by-nc-nd

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12229

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12229

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/alz.12229

repositoryhttps://ddd.uab.cat/record/247512

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8043977

Fields of Study

AdultAlzheimer DiseaseBiomarkersBrainDown SyndromeFemaleHumansMaleMatrix Metalloproteinase 3Matrix Metalloproteinase 9Middle AgedNerve Growth FactorNeuropeptidesSerpinsSignal Transductiontau ProteinsNeuroserpin

MeSH Terms

BrainHumansAlzheimer DiseaseDown SyndromeNerve Growth FactorNeuropeptidestau ProteinsSerpinsSignal TransductionAdultMiddle AgedFemaleMaleMatrix Metalloproteinase 9Matrix Metalloproteinase 3BiomarkersNeuroserpin

Keywords

BloodCerebrospinal fluidPlasmaAlzheimer's diseaseNerve growth factorTissue plasminogen activatorMMP-9CholinergicNeuroserpinBiomarkersDown syndromeMmp-1MetalloproteasesMmp-3ProngfNgf Metabolic Pathway